Citadel Advisors »

Xilio Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $249k 26k 9.58

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
OrbiMed Advisors
Frazier Life Sciences Management
Stonepine Capital Management
Vanguard Capital Management
Sio Capital Management
Adage Capital Partners GP
Merck & Co
Renaissance Technologies
Morgan Stanley
Geode Capital Management
Citadel Advisors
Vanguard Fiduciary Trust
Bridgeway Capital Management
Two Sigma Investments

View all funds holding Xilio Therapeutics